The DOI matches its Crossref record; 209 of the 210 references it cites were found in a registry or an index, and 1 are not checked yet.
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease
Open accessAbstract
Amyloid plaques, mainly composed of abnormally aggregated amyloid β-protein (Aβ) in the brain parenchyma, and neurofibrillary tangles (NFTs), consisting of hyperphosphorylated tau protein aggregates in neurons, are two pathological hallmarks of Alzheimer's disease (AD). Aβ fibrils and tau aggregates in the brain are closely associated with neuroinflammation and synapse loss, characterized by activated microglia and dystrophic neurites. Genome-wide genetic association studies revealed important roles of innate immune cells in the pathogenesis of late-onset AD by recognizing a dozen genetic risk loci that modulate innate immune activities. Furthermore, microglia, brain resident innate immune cells, have been increasingly recognized to play key, opposing roles in AD pathogenesis by either eliminating toxic Aβ aggregates and enhancing neuronal plasticity or producing proinflammatory cytokines, reactive oxygen species, and synaptotoxicity. Aggregated Aβ binds to toll-like receptor 4 (TLR4) and activates microglia, resulting in increased phagocytosis and cytokine production. Complement components are associated with amyloid plaques and NFTs. Aggregated Aβ can activate complement, leading to synapse pruning and loss by microglial phagocytosis. Systemic inflammation can activate microglial TLR4, NLRP3 inflammasome, and complement in the brain, leading to neuroinflammation, Aβ accumulation, synapse loss and neurodegeneration. The host immune response has been shown to function through complex crosstalk between the TLR, complement and inflammasome signaling pathways. Accordingly, targeting the molecular mechanisms underlying the TLR-complement-NLRP3 inflammasome signaling pathways can be a preventive and therapeutic approach for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Among the mentioned PRRs, TLRs play crucial role in the inflammatory responses to pathogenic infection and have been a target for many studies exploring phagocytosis course [201,202,203].”
From MicroRNAs as Regulators of Phagocytosis (2022) · cites this paper as [201]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 389
Qin, P., Ran, Y., Xie, F., Liu, Y., Wei, C., Luan, X., & Wu, J. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117178 · Cited by 30
Farzan, M., Farzan, M., Amini-Khoei, H., Shahrani, M., Bijad, E., Anjomshoa, M., & Shabani, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110112 · Cited by 30
Aβ1-42 promotes microglial activation and apoptosis in the progression of AD by binding to TLR4
Dou, R.-X., Zhang, Y., Hu, X., Gao, F.-L., Zhang, L., Liang, Y.-H., Zhang, Y.-Y., Yao, Y.-P., Li, Y., Zhang, Y., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103428 · Cited by 32
Badr, A. M., Al‐Kharashi, L. A., Attia, H., Alshehri, S., Alajami, H. N., Ali, R., & Mahran, Y. F. (2023) · Pharmaceuticals · doi:10.3390/ph16030337 · Cited by 29
Yin, C., Zhang, M., Cheng, L., Ding, L., Lv, Q., Huang, Z., Zhou, J., Chen, J., Wang, P., Zhang, S., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1430599 · Cited by 29
Microglial dysfunction in Alzheimer's disease: Mechanisms, emerging therapies, and future directions
Azmal, M., Paul, J. K., Prima, F. S., Haque, A. N. M. S. N. B., Meem, M., & Ghosh, A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115374 · Cited by 30
Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
Fülöp, T., Tripathi, S., Rodrigues, S., Desroches, M., Bunt, T., Eiser, A. R., Bernier, F., Beauregard, P. B., Barron, A. E., Khalil, A., et al. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s264910 · Cited by 27
Li, Q., Rubin, L., Silva, M., Li, S., Yang, C., Lazarovici, P., & Zheng, W. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3777021 · Cited by 28
Ma, Y., Li, W., Chang, F., Wang, Y., Jiang, H., & Yang, W. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220564 · Cited by 27
Han, J., Zhang, X., Kang, L., & Guan, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03443-1 · Cited by 26
Quijano, A., Díaz-Ruiz, C., López-López, A., Villar‐Cheda, B., Muñoz, A., Rodriguez-Perez, A. I., & Labandeira-García, J. L. (2022) · Antioxidants · doi:10.3390/antiox11020329 · Cited by 26
MicroRNAs as Regulators of Phagocytosis
Gierlikowski, W., & Gierlikowska, B. (2022) · Cells · doi:10.3390/cells11091380 · Cited by 25
López-Rodríguez, A. B., Decouty‐Pérez, C., Farré‐Alins, V., Palomino‐Antolín, A., Narros‐Fernández, P., & Egea, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081550 · Cited by 25
Neuroinflammation: Molecular Mechanisms And Therapeutic Perspectives
Meccariello, R., Marino, M., Mele, E., Pastorino, G. M. G., Operto, F. F., Santoro, A., & Viggiano, A. (2022) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524922666220929153215 · Cited by 29
Ayyubova, G., Kodali, M., Upadhya, R., Madhu, L. N., Attaluri, S., Somayaji, Y., Shuai, B., Rao, S., Shankar, G., & Shetty, A. K. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02971-y · Cited by 25
Liu, D., Yang, A., Li, Y., Li, Z., You, P., Zhang, H., Quan, S., Sun, Y., Zeng, Y., Ma, S., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.01.005 · Cited by 25
de Boer, E. C. W., van Mourik, A. G., & Jongerius, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.578069 · Cited by 24
Md, S., Alhakamy, N. A., Alfaleh, M. A., Afzal, O., Altamimi, A. S. A., Iqubal, A., & Shaik, R. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111116 · Cited by 24
Petrisko, T. J., Gómez-Arboledas, Á., & Tenner, A. J. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.003 · Cited by 23
Gagliardi, S., Truffi, M., Tinelli, V., Garofalo, M., Pandini, C., Ramusino, M. C., Perini, G., Costa, A. C., Negri, S., Mazzucchelli, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169237 · Cited by 25
Li, Y., Khan, N., Ritzel, R. M., Lei, Z., Allen, S., Faden, A. I., & Wu, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02881-z · Cited by 24
Chen, H., Ma, Y., Chen, M., Chen, J., & Jin, C. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1728 · Cited by 24
Taravat, M., Asadpour, R., Jozani, R. J., Fattahi, A., & Khordadmehr, M. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.103992 · Cited by 23
Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse
Gaboriaud, C., Lorvellec, M., Rossi, V., Dumestre‐Pérard, C., & Thielens, N. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869720 · Cited by 24
Baky, N. A. A., Al‐Najjar, A. H., Elariny, H. A., Sallam, A. S., & Mohammed, A. A. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109282 · Cited by 22
Manna, K., Khan, Z. S., Saha, M., Mishra, S., Gaikwad, N. N., Bhakta, J. N., Banerjee, K., & Saha, K. D. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s338888 · Cited by 22
Kinra, M., Ranadive, N., Nampoothiri, M., Arora, D. S., & Mudgal, J. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02743-8 · Cited by 22
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-β-Induced Neuroinflammation in Alzheimer’s Disease
Zhu, M., Liu, Y., Chen, C., Chen, H., Ni, W., Song, Y., Lv, B., Hua, F., Cui, G., & Zhang, Z. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240012 · Cited by 23
Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease
Ayyubova, G., & Fazal, N. (2024) · Brain Sciences · doi:10.3390/brainsci14050434 · Cited by 20
Balakrishnan, R., Kang, S.-I., Lee, J. Y., Rho, Y., Kim, B.-K., & Choi, D. (2024) · Aging and Disease · doi:10.14336/ad.2024.1362 · Cited by 22
Kabel, A. M., Arab, H. H., Atef, A., & Estfanous, R. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120396 · Cited by 21
Marconi, G. D., Rocca, Y. D., Fonticoli, L., Guarnieri, S., Carradori, S., Rajan, T. S., Pizzicannella, J., & Diomede, F. (2022) · Antioxidants · doi:10.3390/antiox11020386 · Cited by 21
Rodríguez-Viso, P., Domene, A., Vélez, D., Devesa, V., Monedero, V., & Zúñiga, M. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113224 · Cited by 21
Yang, Z., Nicholson, S. E., Cancio, T. S., Cancio, L. C., & Li, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1100461 · Cited by 21
Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
Ferrer, I. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-3806 · Cited by 25
Jaén, R. I., Povo-Retana, A., Rosales-Mendoza, C., Capillas-Herrero, P., Sánchez-García, S., Martín-Sanz, P., Mojena, M., Prieto, P., & Boscá, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169114 · Cited by 20
Singh, A., & Singh, L. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00672-8 · Cited by 21
Decoding NLRP3 Inflammasome Activation in Alzheimer’s Disease: A Focus on Receptor Dynamics
Maurya, R., Sharma, A., & Naqvi, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04918-1 · Cited by 22
Glycolytic reprogramming during microglial polarization in neurological diseases
Li, X., Fang, C., Li, Y., Xiong, X., Xu, X., & Gu, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648887 · Cited by 23
Liu, Y., Wei, Y., Wu, L., Lin, X., Sun, R., Chen, H., Shen, S., & Deng, G. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.839174 · Cited by 21
Luan, Y., Luan, Y., Jiao, Y., Liu, H., Huang, Z., Feng, Q., Pei, J., Yang, Y., & Ren, K. (2023) · Aging and Disease · doi:10.14336/ad.2023.1130 · Cited by 21
Abu‐Elfotuh, K., Hamdan, A. M., Mohamed, S. A., Bakr, R. O., Ahmed, A. H., Atwa, A. M., Hamdan, A. M., Alanzai, A. G., Alnahhas, R. K., Gowifel, A. M. H., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117731 · Cited by 20
Zhu, H., Guan, Y., Wang, W., Liu, X., Wang, S., Zheng, R., Liu, L., Liu, L., & Huang, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112068 · Cited by 22
From Low-Grade Inflammation in Osteoarthritis to Neuropsychiatric Sequelae: A Narrative Review
Naumovs, V., Groma, V., & Mednieks, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416031 · Cited by 20
Han, L., Tieliwaerdi, N., & Li, X. (2024) · Tuberculosis · doi:10.1016/j.tube.2024.102502 · Cited by 19
Idrissi, F. E., Gressier, B., Devos, D., & Bélarbi, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.630003 · Cited by 18
Opinion: Endothelial Cells - Macrophage-Like Gatekeepers?
Stolarz, A. J., Mu, S., Zhang, H., Fouda, A. Y., Rusch, N. J., & Ding, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902945 · Cited by 18
Gao, X., Cao, Z., Tan, H., Li, P., Su, W., Wan, T., & Guo, W. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.903472 · Cited by 18
Lv, H., He, Y., Wu, J., Li, Z., & Zheng, Y. (2022) · Journal of Veterinary Science · doi:10.4142/jvs.22185 · Cited by 18
Lo, J., Wu, H., Liu, C., Chang, K., Lee, P., Liu, P., Huang, S., Wu, P., Lin, T.-C., Lai, Y., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087300 · Cited by 20
Dong, W.-R., Li, Y., Liu, T., Zhou, G., & Chen, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1229772 · Cited by 18
Lv, H., Xia, S., He, Y., Qiao, C., Liu, J., Guo, J., & Li, S. (2024) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-024-01019-w · Cited by 17
Shi, Y., Hu, Y., Li, J., Chen, H., Zhong, Q., Ma, X., Li, X., Zhang, S., Zhuang, S., & Liu, N. (2025) · Small · doi:10.1002/smll.202409362 · Cited by 17
Jiang, Y., Wang, N., Liu, J., Li, J., Chang, L., Yang, C., Chen, Z., Huang, W., Wang, J., Lang, X., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01203-8 · Cited by 17
Emerging roles for innate and adaptive immunity in tauopathies
Johnson, A. M., & Lukens, J. R. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116232 · Cited by 19
Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets
Ahmadi, S., Khaledi, S., Ahmadi, K., & Hassanzadeh, K. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70688 · Cited by 20
Guo, X., Liu, H. N., Song, Y., Wang, J., Liu, D., Zheng, Z., Li, J., Li, B., Song, A., He, W., et al. (2026) · MedComm · doi:10.1002/mco2.70497 · Cited by 26
Dai, Y., Liu, S., Chen, J., Liu, L., Zhou, C., & Zuo, Y. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.004 · Cited by 19
Zeng, X., Deng, X., Ni, Y., Bi, H., Jiang, M., Wang, D., Dong, P., Xiao, Y., & Jiang, M. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11887 · Cited by 17
Protective Role of Electroacupuncture Against Cognitive Impairment in Neurological Diseases
Xin, Y., Zhou, S., Chu, T., Zhou, Y., & Xu, A. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22999240209102116 · Cited by 18
Identification of new potent NLRP3 inhibitors by multi-level in-silico approaches
Hayat, C., Subramaniyan, V., Alamri, M. A., Wong, L. S., Khalid, A., Abdalla, A. N., Afridi, S. G., Kumarasamy, V., & Wadood, A. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01178-3 · Cited by 17
Azargoonjahromi, A. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae066 · Cited by 17
Kodali, M., Madhu, L. N., Somayaji, Y., Attaluri, S., Huard, C., Panda, P. K., Shankar, G., Rao, S., Shuai, B., Gonzalez, J. J., et al. (2024) · Aging Cell · doi:10.1111/acel.14398 · Cited by 18
Bhardwaj, V., Kumari, S., Dhapola, R., Sharma, P., Beura, S. K., Singh, S. K., Vellingiri, B., & HariKrishnaReddy, D. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01598-6 · Cited by 18
Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms
Mohammadkhanizadeh, A., Sheibani, M., Taherkhani, S., Nourabadi, D., Mohamadi-Zarch, S.-M., Nikbakht, F., & Azizi, Y. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100189 · Cited by 18
Abu‐Elfotuh, K., Mahran, Y., Gazzar, W. B. E., Youssef, H. S., Hamdan, A. M., Albalawi, T. M., Alsunbul, M., Alqahtani, R. A., & Mohammed, A. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031260 · Cited by 16
Akif, A., Nguyen, T. T. M., Liu, L., Xu, X., Kulkarni, A. A., Jiang, J., Zhang, Y., & Hao, J. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00665-6 · Cited by 16
Ding, J., Shen, L., Ye, Y., Hu, S., Ren, Z., Liu, T., Dai, J., Li, Z., Wang, J., Luo, Y., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.861340 · Cited by 16
Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
Vlieger, L. D., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103340 · Cited by 16
Saha, P., & Ahmad, F. (2024) · ACS Omega · doi:10.1021/acsomega.3c07178 · Cited by 17
Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets
Gu, X., Long, Q., Qi, Q., Zhou, J., Chen, S., & Wang, L. (2024) · BioScience Trends · doi:10.5582/bst.2023.01288 · Cited by 17
The Nlrp3 inflammasome – the evolving story of its positive and negative effects on hematopoiesis
Ratajczak, M. Z., & Kucia, M. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000658 · Cited by 16
Inflammasome activation and assembly in Huntington’s disease
Furlam, T. D. O., Roque, I. G., da Silva, E. W. M., Vianna, P. P., Valadão, P. A. C., Guatimosim, C., Teixeira, A. L., & de Miranda, A. S. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.09.002 · Cited by 16
The role of Pim-1 kinases in inflammatory signaling pathways
Baek, H. S., Kim, N., Park, J. W., Kwon, T. K., & Kim, S. (2024) · Inflammation Research · doi:10.1007/s00011-024-01924-2 · Cited by 15
Qoreishi, M., Panahi, M., Dorodi, O., Ghanbari, N., & Jousheghan, S. S. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02232-4 · Cited by 16
Novel inflammasome and oxidative modulators in Parkinson’s disease: A prospective study
Roy, A., Banerjee, R., Choudhury, S., Chatterjee, K., Mondal, B., Dey, S., & Kumar, H. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136768 · Cited by 15
Wongpun, J., Chanmanee, T., Tocharus, J., Chokchaisiri, R., Chaichompoo, W., Suksamrarn, A., & Tocharus, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110181 · Cited by 15
Che, H., Wang, X., He, S.-S., Dong, X., Lv, L., Xie, W., & Li, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128539 · Cited by 15
Sim, A. Y., Kim, J. Y., Lee, Y., & Lee, J. E. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115271 · Cited by 15
Byun, E., Song, H.-Y., Kim, W. S., Han, J. M., Seo, H. S., Park, W. Y., Kim, K., & Byun, E. (2021) · Molecules · doi:10.3390/molecules26061532 · Cited by 16
Yang, Z., Nunn, M. A., Le, T. D., Simovic, M. O., Edsall, P. R., Liu, B., Barr, J. L., Lund, B. J., Hill-Pryor, C., Pusateri, A. E., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15970 · Cited by 15
Zhao, B., & Zhao, B. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.02.010 · Cited by 15
Mitophagy in Alzheimer's disease and its potential as a therapeutic target
Wei, J., Xiao, T., Lyu, J., Zhao, Y., Zhang, Y., Du, X., He, Y., Zhao, M., Yang, X., Yao, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107162 · Cited by 13
Yang, H. C., Song, R., Xie, Y., Qian, Q., Wu, Z., Han, S., & Li, X. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c01966 · Cited by 14
Tsukalov, I., Sánchez‐Cerrillo, I., Rajas, O., Ávalos, E., Iturricastillo, G., Esparcia, L., Buzón, M. J., Genescà, M., Scagnetti, C., Popova, O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46322-8 · Cited by 13
Yesitayi, G., Wang, Q., Wang, M., Ainiwan, M., Kadier, K., Aizitiaili, A., Yitong, M., & Ma, X. (2024) · Microbes and Infection · doi:10.1016/j.micinf.2024.105406 · Cited by 13
Huang, L., Liu, M., Li, Z., Li, B., Wang, J., & Zhang, K. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00865 · Cited by 13
A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease
Yang, Z., Liu, J., Wei, S., Deng, J., Feng, X., Liu, S., & Liu, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1077222 · Cited by 17
Liu, J., Lin, Y., Yang, Y., Guo, Y., Shang, Y., Zhou, B., Liu, T., Fan, J., & Wei, C. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115149 · Cited by 12
Morais, G. P., Neto, I. V. D. S., Veras, A. S. C., Teixeira, G. R., Paroschi, L. O., Pinto, A. P., dos Santos, J. R., Alberici, L. C., Cintra, D. E., Pauli, J. R., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05066-2 · Cited by 14
Adaptive immunity in the neuroinflammation of Alzheimer’s disease
Liu, H., Chen, Y., Zhang, J., & Chen, X. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003695 · Cited by 13
Chamkouri, H., & Mohavi, S. M. (2025) · Neuroglia · doi:10.3390/neuroglia6030031 · Cited by 13
Dong, M., Qian, Y., Geng, Y., Wang, R., Wang, Y., Cai, J., Wang, X., Huang, Y., Liu, Y., Liu, W., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378007 · Cited by 12
Wang, X.-Y., Zhou, Y., Liu, Y., Mo, T., Chen, Z., Zhang, Y. L., Yang, L., & Liu, P. (2025) · Inflammation · doi:10.1007/s10753-025-02254-z · Cited by 12
Sherwani, M. A., Abdelgawad, A. S., Chung, M. G., Ibrahim, S., Eraslan, M., Elmets, C. A., & Yusuf, N. (2021) · Cancers · doi:10.3390/cancers13215406 · Cited by 12
Li, Y., Shi, H., Chen, T., Xue, J., Wang, C., Peng, M., & Si, G. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-6762 · Cited by 12
CTRP5 Attenuates Doxorubicin-Induced Cardiotoxicity Via Inhibiting TLR4/NLRP3 Signaling
Zhang, Z., Peng, J., Hu, Y., Zeng, G., Du, W., & Shen, C. (2023) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-023-07464-x · Cited by 12
Uberti, F., Trotta, F., Cavalli, R., Galla, R., Caldera, F., Ferrari, S., Mulè, S., Brovero, A., Molinari, C. G., Pagliaro, P., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042189 · Cited by 13
Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
Lalwani, R. C., Volmar, C., Wahlestedt, C., Webster, K. A., & Shehadeh, L. A. (2023) · Biomedicines · doi:10.3390/biomedicines11123232 · Cited by 13
Podocytes from hypertensive and obese mice acquire an inflammatory, senescent, and aged phenotype
McKinzie, S. R., Kaverina, N. V., Schweickart, R. A., Chaney, C. P., Eng, D. G., Pereira, B. M. V., Kestenbaum, B. R., Pippin, J. W., Carroll, T. J., Wessely, O., et al. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00417.2023 · Cited by 11
Metadata
- Authors
- Yang, J., Wise, L., & Fukuchi, K.-I.
- Affiliations
- Peoria campus of the University of Illinois System (US)
- Corresponding author
- Fukuchi, Ken-ichiro
- ORCID
- Yang, Junling
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-23
- Volume
- 11
- Pages
- 724-724
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC7190872
- OpenAlex
- W3019520705
- Cited by
- 387
- References
- 210
- Citations by year
- 2026: 64 · 2025: 73 · 2024: 72 · 2023: 73 · 2022: 67 · 2021: 30 · 2020: 7
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute on Aging (R21AG064811, R21AG056862, R21AG054937, R21AG062179, R21AG053719)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, TLR4, NLRP3 inflammasome, complement system, innate immunity, microglia, amyloid-beta, neurofibrillary tangles, neuroinflammation, synaptic loss, systemic inflammation, neurodegeneration, phagocytosis, synaptic pruning
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Animals, Complement System Proteins, Humans, Signal Transduction, Amyloid beta-Peptides, Toll-Like Receptor 4, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review